Needham & Company Reiterates Buy Rating, $20 PT on CorMedix (CRMD), Sees Latest Developments Removing Some Overhang

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/2/2026

1. SPY
2. MDT
3. SPGI
4. USO
5. AAPL
6. DELL
7. NIO
8. ENOV
9. AON
10. A

Go back to Needham & Company Reiterates Buy Rating, $20 PT on CorMedix (CRMD), Sees Latest Developments Removing Some Overhang
CORMEDIX, Inc. (NASDAQ: CRMD) Delayed: 8.38 +0.12 (1.45%)
Previous Close $8.26    52 Week High $4.54 
Open $8.25    52 Week Low $1.15 
Day High $8.49    P/E N/A 
Day Low $8.18    EPS $-0.55 
Volume 880,476